Pentose Phosphate Pathway (PPP)

Overview

The Pentose Phosphate Pathway (PPP), also known as the Hexose Monophosphate (HMP) Shunt or Phosphogluconate Pathway, is a crucial metabolic pathway that operates in the cytosol of cells. It serves two primary purposes: the generation of NADPH and the production of ribose-5-phosphate (R5P). The pathway consists of two functional phases: an oxidative (irreversible) phase that produces NADPH, and a non-oxidative (reversible) phase that interconverts sugars.

• Cellular location: Cytosol

• Primary purposes:

  • Generation of NADPH

  • Production of ribose-5-phosphate (R5P)

• Phases:

  • Oxidative (irreversible): NADPH production

  • Non-oxidative (reversible): Sugar interconversions

Glucose-6-Phosphate: Central Control Point

Branch Point Metabolite

Glucose-6-phosphate (G6P) is a key metabolite that links glycolysis, glycogen synthesis, and the pentose phosphate pathway. The fate of G6P depends on cellular needs:

• PPP: NADPH & ribose-5-phosphate

• Glycolysis: ATP & pyruvate

• Glycogenesis: Glycogen storage

The PPP does not use free glucose; it uses G6P exclusively. Regulation at the level of glucose-6-phosphate dehydrogenase (G6PD) determines whether G6P enters the PPP.

Cells Need PPP Products

Functions of NADPH and Ribose-5-Phosphate

• NADPH is required for:

  • Fatty acid synthesis (Acetyl-CoA carboxylase is a key enzyme)

  • Cholesterol & steroid hormone synthesis (HMG-CoA reductase is a key enzyme)

  • Bile acid synthesis (7-alpha hydroxylase is a key enzyme)

  • Nitric oxide synthesis (Arginine is the precursor; requires BH4)

  • Cytochrome P450 detoxification (detoxifies drugs and toxins; requires heme and vitamin C)

  • Maintenance of reduced glutathione (GSH) (requires glutathione peroxidase [selenium] and glutathione reductase [FAD])

• Ribose-5-phosphate is required for:

  • Nucleotide synthesis (DNA, RNA)

  • ATP, NAD+, FAD, CoA synthesis

Oxidative Phase

Key Reactions and Products

The oxidative phase is catalyzed by glucose-6-phosphate dehydrogenase (G6PD) and involves irreversible oxidative decarboxylation:

• Converts glucose-6-phosphate to ribulose-5-phosphate

• Produces: 2 NADPH, 1 CO2

• This is the rate-limiting step that controls the entire pathway flux.

Equation:

Ribulose-5-Phosphate Structure

Chemical Properties

• Product of the oxidative phase

• Ketopentose (five-carbon ketose sugar)

• Open-chain form: carbonyl at C2, phosphate at C5

• Precursor for ribose-5-phosphate and xylulose-5-phosphate

Regulation: NADPH/NADP+ Ratio

Feedback Mechanism

• High NADPH/NADP+ ratio inhibits G6PD and decreases PPP flux

• Low NADPH/NADP+ ratio activates G6PD and increases PPP flux

• PPP is demand-driven, not substrate-driven

Hormonal Regulation (Liver)

Insulin and Glucagon Effects

• High insulin/glucagon ratio:

  • Increases G6PD gene expression

  • Increases NADPH for lipogenesis

• High glucagon/insulin ratio:

  • Decreases G6PD expression

  • Decreases PPP activity

  • PPP aligns with fed vs fasting state

Non-Oxidative Phase

Reversible Sugar Interconversions

The non-oxidative phase is fully reversible and allows the conversion of pentoses to glycolytic intermediates. This phase enables:

• R5P synthesis without NADPH production

• NADPH synthesis without R5P accumulation

• No redox reactions occur

Non-Oxidative Enzymes

• Isomerase: Ribulose-5-phosphate → Ribose-5-phosphate

• Epimerase: Ribulose-5-phosphate → Xylulose-5-phosphate

• Transketolase: Transfers 2-carbon units

• Transaldolase: Transfers 3-carbon units

Transketolase Cofactor

Thiamine Pyrophosphate (TPP)

• Cofactor: Thiamine pyrophosphate (TPP)

• Vitamin required: Vitamin B1 (Thiamine)

• Other TPP-dependent enzymes:

  • Pyruvate dehydrogenase (complex)

  • α-Ketoglutarate dehydrogenase (complex)

  • Branched-chain α-ketoacid dehydrogenase (complex)

  • Transketolase

RBC Transketolase & Thiamine Status

• RBCs rely heavily on PPP for NADPH

• Low transketolase activity suggests thiamine deficiency

• Activity increases after TPP addition, confirming deficiency

• Used clinically to assess functional B1 status

Carbon Flow Scenarios in PPP

Need NADPH Only

• Oxidative phase produces NADPH

• Non-oxidative phase converts sugars to F6P & G3P

• Carbons recycled back to G6P; pathway repeats

• Maximizes NADPH output

• Net reaction:

Need NADPH + R5P

• Oxidative phase runs

• Ribulose-5-phosphate → Ribose-5-phosphate

• Products used directly

• Minimal carbon recycling

• Typical in rapidly dividing cells

Need R5P Only

• Glycolytic intermediates (F6P, G3P) enter non-oxidative PPP

• Oxidative phase bypassed

• No NADPH produced

• Common in nucleotide-demand states

Need NADPH + Pyruvate

• Oxidative phase generates NADPH

• Non-oxidative phase converts pentoses to F6P & G3P

• Glycolysis converts intermediates to pyruvate

• No net R5P accumulation

• Stoichiometry: 3 G6P → 2 F6P + 1 G3P

Summary Table: Cellular Needs and PPP Direction

Additional info: The PPP is especially important in tissues with high rates of fatty acid or steroid synthesis (e.g., liver, adipose tissue, adrenal cortex) and in red blood cells for maintaining reduced glutathione and protecting against oxidative damage.